Hossein Haji Ali Afzali
Hossein Haji Ali Afzali
Health economist, The University of Adelaide
Verified email at adelaide.edu.au
Cited by
Cited by
Efficiency measurement for hospitals owned by the Iranian social security organisation
H Hajialiafzali, JR Moss, MA Mahmood
Journal of medical systems 31 (3), 166-172, 2007
Estimating the reference incremental cost-effectiveness ratio for the Australian health system
LC Edney, HHA Afzali, TC Cheng, J Karnon
Pharmacoeconomics 36 (2), 239-252, 2018
When to use discrete event simulation (DES) for the economic evaluation of health technologies? A review and critique of the costs and benefits of DES
J Karnon, HHA Afzali
Pharmacoeconomics 32 (6), 547-558, 2014
Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development …
HHA Afzali, J Karnon, T Merlin
Medical Decision Making 33 (3), 325-332, 2013
A critical review of model-based economic studies of depression
HHA Afzali, J Karnon, J Gray
Pharmacoeconomics 30 (6), 461-482, 2012
A conceptual framework for selecting the most appropriate variables for measuring hospital efficiency with a focus on Iranian public hospitals
HHA Afzali, JR Moss, MA Mahmood
Health Services Management Research 22 (2), 81-91, 2009
Model performance evaluation (validation and calibration) in model-based studies of therapeutic interventions for cardiovascular diseases
HHA Afzali, J Gray, J Karnon
Applied health economics and health policy 11 (2), 85-93, 2013
The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children
B Wang, HHA Afzali, H Marshall
Vaccine 32 (37), 4791-4798, 2014
Exploring structural uncertainty in model-based economic evaluations
HHA Afzali, J Karnon
Pharmacoeconomics 33 (5), 435-443, 2015
Practice nurse involvement in general practice clinical care: policy and funding issues need resolution
HHA Afzali, J Karnon, J Beilby, J Gray, C Holton, D Banham
Australian Health Review 38 (3), 301-305, 2014
Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis
B Wang, R Santoreneos, L Giles, HHA Afzali, H Marshall
Vaccine 37 (21), 2768-2782, 2019
Community, parental and adolescent awareness and knowledge of meningococcal disease
B Wang, M Clarke, HHA Afzali, H Marshall
Vaccine 32 (18), 2042-2049, 2014
The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children
B Wang, M Clarke, N Thomas, S Howell, HHA Afzali, H Marshall
The Pediatric infectious disease journal 33 (3), 316-318, 2014
Addressing the challenge for well informed and consistent reimbursement decisions
HHA Afzali, J Karnon
Pharmacoeconomics 29 (10), 823-825, 2011
A proposed model for economic evaluations of major depressive disorder
HHA Afzali, J Karnon, J Gray
The European Journal of Health Economics 13 (4), 501-510, 2012
A risk adjusted cost‐effectiveness analysis of alternative models of nurse involvement in obesity management in primary care
J Karnon, HHA Afzali, J Gray, C Holton, D Banham, J Beilby
Obesity 21 (3), 472-479, 2013
Costs of invasive meningococcal disease: a global systematic review
B Wang, R Santoreneos, H Afzali, L Giles, H Marshall
PharmacoEconomics 36 (10), 1201-1222, 2018
Governments need better guidance to maximise value for money: the case of Australia’s Pharmaceutical Benefits Advisory Committee
D Carter, A Vogan, HHA Afzali
Applied health economics and health policy 14 (4), 401-407, 2016
A risk‐adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes
H Haji Ali Afzali, J Gray, J Beilby, C Holton, D Banham, J Karnon
Diabetic medicine 30 (7), 855-863, 2013
Adolescent confidence in immunisation: Assessing and comparing attitudes of adolescents and adults
B Wang, L Giles, HHA Afzali, M Clarke, J Ratcliffe, G Chen, H Marshall
Vaccine 34 (46), 5595-5603, 2016
The system can't perform the operation now. Try again later.
Articles 1–20